Výsledky vyhledávání - "Sharif M. Uddin"

S875 The Evolution of Clinical Trial Design in Ulcerative Colitis: Interpreting Future Endpoints Based on Post-Hoc Analyses of the Vedolizumab Phase 3 Trials GEMINI 1 and VISIBLE 1

Autor: Rana Khan, Sharif M. Uddin, Karen Lasch, Bruce E. Sands, William J. Sandborn

Publikováno v: American Journal of Gastroenterology. 116:S410-S410

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::10919b46292c556bef28dedef524d298
https://doi.org/10.14309/01.ajg.0000777032.10922.69

Zobrazit plný text záznamu

Sa083 SYMPTOMATIC IMPROVEMENT WITH VEDOLIZUMAB THERAPY FOR CROHN'S DISEASE STRATIFIED BY DISEASE ACTIVITY AND PRIOR TUMOR NECROSIS FACTOR ANTAGONIST FAILURE: POST HOC ANALYSES FROM THE GEMINI 2 TRIAL

Autor: Geert R. D'Haens, Sharif M. Uddin, Ninfa Candela, Theresa C. Peterson, Marla Dubinsky, Karen Lasch, Jean-Frederic Colombel

Publikováno v: Gastroenterology. 160:S-414

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f5e91c638cda377e26118dcfa5518059
https://doi.org/10.1016/s0016-5085(21)01696-6

Zobrazit plný text záznamu

Su565 REAL-WORLD EFFECTIVENESS AND SAFETY OF TEDUGLUTIDE IN ADULT SHORT BOWEL SYNDROME: A META-ANALYSIS

Autor: Lyann Ursos, Kishore Iyer, Bram P. Raphael, Charlotte C. Ronveaux, Sharif M. Uddin, Jeanne Jiang, Shirley Paski

Publikováno v: Gastroenterology. 160:S-741

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::954a548fc487eab8bf05800b1fc9e183
https://doi.org/10.1016/s0016-5085(21)02482-3

Zobrazit plný text záznamu

Sa1879 EFFICACY AND SAFETY OF VEDOLIZUMAB REINITIATION FOLLOWING TREATMENT INTERRUPTION: POST HOC ANALYSIS OF THE VISIBLE TRIAL DATA

Autor: Sharif M. Uddin, Silvio Danese, Krisztina Kisfalvi, Ninfa Candela, Johan P. Jansson, William J. Sandborn, Jingjing Chen, Karen Lasch

Publikováno v: Gastroenterology. 158:S-462

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::094bb8014e3949e81d7db0e4c46cfcfe
https://doi.org/10.1016/s0016-5085(20)31838-2

Zobrazit plný text záznamu

Sa1880 DOSE ESCALATION OF SUBCUTANEOUS VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS: A POST HOC ANALYSIS OF THE VISIBLE TRIAL DATA

Autor: Jingjing Chen, Karen Lasch, Krisztina Kisfalvi, Johan P. Jansson, Ninfa Candela, Douglas C. Wolf, Sharif M. Uddin, Geert R. D'Haens, William J. Sandborn

Publikováno v: Gastroenterology. 158:S-463

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8571a74b3e4e2e28e2be559c398e4b4b
https://doi.org/10.1016/s0016-5085(20)31839-4

Zobrazit plný text záznamu

Clinical Features at Baseline are Not Clearly Associated with Symptomatic Placebo Response in Adolescents and Adults with Eosinophilic Esophagitis During a Placebo Run-in Period of a Double-Blind, Randomized, Controlled Trial of Budesonide Oral Suspension

Autor: David A. Katzka, Sharif M. Uddin, Evan S. Dellon, James W. Williams, Margaret H. Collins, Ikuo Hirano

Publikováno v: Gastroenterology. 152:S854

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5b5687541d1153be8451b53dc130f2f9
https://doi.org/10.1016/s0016-5085(17)32941-4

Zobrazit plný text záznamu